Showing results (2061-2070 of 2,338) with videos related to

Sort By:
Pageof 234
British Journal of Cancer|June 28, 2017
Chemotherapy with radiotherapy influences time-to-development of radiation-induced sarcomas: a multicenter studyA Y Zhang, I Judson, C Benson, et al.
Molecular Cancer Therapeutics|June 11, 2009
Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumorsRichard D Baird, Jos Kitzen, Paul A Clarke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2011
A phase I study of the heat shock protein 90 inhibitor alvespimycin (17-DMAG) given intravenously to patients with advanced solid tumorsSimon Pacey, Richard H Wilson, Mike Walton, et al.
ALTEX|January 23, 2013
Perspectives on validation of high-throughput assays supporting 21st century toxicity testingRichard Judson, Robert Kavlock, Matthew Martin, et al.
Plos One|January 21, 2010
Recombination and its impact on the genome of the haplodiploid parasitoid wasp NasoniaOliver Niehuis, Joshua D Gibson, Michael S Rosenberg, et al.
British Journal of Cancer|May 30, 2018
Author Correction: Chemotherapy with radiotherapy influences time-to-development of radiation-induced sarcomas: a multicenter studyA Y Zhang, I Judson, C Benson, et al.
Annals of the American Thoracic Society|September 24, 2020
Evaluating the Minimal Clinically Important Difference of the King's Sarcoidosis Questionnaire in a Multicenter Prospective StudyRobert P Baughman, Marc A Judson, Jennifer L Beaumont, et al.
International Orthopaedics|July 13, 2026
Functional recovery effects of growth factor-stimulated mesenchymal stromal cells in a Wistar rat model of ankle sprain injuryQuan Fu Gan, Li Zhang, Venkatesh Ramaswamy Naik, et al.
Open Forum Infectious Diseases|December 7, 2023
Risk Factors for Hospitalization and Effect of Immunosuppression on Clinical Outcomes Among an Urban Cohort of Patients With MpoxWilliam M Garneau, Joyce L Jones, Gabriella M Dashler, et al.
Frontiers in Toxicology|June 8, 2023
From vision toward best practices: EvaluatingAnthony J F Reardon, Reza Farmahin, Andrew Williams, et al.
Pageof 234